After developing an interest in fighting cancer in medical school, I was fortunate to work with and learn from leadersin the field of genitourinary oncology during internship, residency, and fellowship training. I feel fortunate to have joined the faculty at Weill Cornell to work with renowned mentors and colleagues in both medical oncology and urology. Together I am confident we will make progress towards increasing the cure rate and decreasing suffering from these diseases.
Scott T. Tagawa, MD was initially appointed to the faculty of Weill Cornell Medical College in April, 2007 as Assistant Professor of Medicine and Urology and Assistant Attending Physician in the Division of Hematology and Medical Oncology. He joined the Genitourinary Oncology Program within the Solid Tumor Service in the Division of Hematology and Medical Oncology.
After earning his BS from Georgetown University, Dr. Tagawa received his MD at the University of Southern California School of Medicine. After completing his Internship and Residency training there, he was Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center he took the lead in developing genitourinary clinical trials. He was recruited to Weill Cornell Medical College in 2007. His research has involved clinical and translational investigations in genitourinary tumors and thrombosis in malignancy.
As the Medical Director of the Genitourinary Oncology Research Program, he leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He also serves as Associate Director of Clinical Research for the Division of Hematology and Medical Oncology and Chair of the Clinical Study Evaluation Committee. He was promoted to Associate Professor of Clinical Medicine and Urology in 2013. He is the WCMC principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a member of the Genitourinary Committee. He currently serves as a member of the scientific committee for the American Society of Clinical Oncologists.
Please contact the doctor's office to verify that your insurance is accepted.
Aetna [HMO, Medicare, PPO]
Aetna [Weill Cornell Employee Plan]
Affinity [Access (Exchange)]
Emblem Select Care
Emblem/HIP [Medicaid, Medicare]
Empire Blue Cross Blue Shield [Blue Priority, Child Health Plus, EPO, HMO, Mediblue (Senior), Pathway (Exchange), PPO]
Empire Blue Cross Blue Shield [Pathway Enhanced]
Oxford Health Plans [Freedom, Liberty, Medicare Advantage]
Rockefeller University - CoreSource
UnitedHealthcare [Community Plan, Compass (Exchange), HMO, Medicare]
1998 University of Southern California School of Medicine
Residency: 2001 University of Southern California Medical Center
Fellowship: 2005 University of Southern California Medical Center
525 East 68th Street Starr Pavilion Room 900New York, NY 10065
Phone: (646) 962-2072
Fax: (646) 962-1603
Associate Professor of Urology at Weill Cornell Medical College
Associate Professor of Medicine at at Weill Cornell Medical College, Cornell Univ